newsfilter
← Latest News
Business Wire·

MorphoSys AG Reports First Quarter 2024 Financial Results

– Entered into Business Combination Agreement to be acquired by Novartis for € 68.00 per share in cash, representing a total equity value of € 2.7 billion – Received all mandatory antitrust approvals for the proposed